Sera Prognostics Inc

Insider buying spikes at Sera Prognostics as CEO and senior officers pile up shares, signaling confidence amid volatile pricing and negative earnings.

Insider buying at Sera Prognostics signals confidence in its rising pregnancy‑diagnostics platform—executive equity grants suggest a future earnings rebound amid volatility.

CEO Zhenya Lindgardt’s March 12 insider buys at Sera Prognostics signal renewed confidence amid flat share price and soaring social‑media buzz—an insider‑confidence story investors shouldn’t miss.

Insightful look at Sera Prognostics’ insider sales shows tax‑withholding moves, not confidence shifts—watch future Form 4 filings for signals.

Explore how Sera Prognostics’ insider sell‑to‑cover trades reflect routine tax‑funding rather than strategic selling, and what that means for investors and its diagnostic pipeline.

Insightful analysis of Sera Prognostics insider sales, showing how recent 2,000‑share liquidation reflects leadership confidence and its impact on the company’s declining stock and promising cell‑based diagnostics pipeline.